The message is clear: Compounding and dispensing essentially a copy of commercially available semaglutide or tirzepatide without medical necessity violates the Food, Drug, and Cosmetic Act (FD&C Act) and can result in legal action
Regarding the most likely etiology of our patients hemorrhage, elevated blood pressure on presentation along with CT- and catheter angiography showing no vascular malformation or aneurysm therefore makes hypertensive microangiopathy most likely
Branded Medications FuturHealth offers both compounded semaglutide and FDA-approved name-brand options like Wegovy and Ozempic
The best injection sites for semaglutide include the abdomen (avoiding a two-inch radius around the navel), the front of the thigh, and the back of the upper arm
These are indirect comparisons across different trial populations, so they need to be read carefully
pharmacies and is positioned as a non-approved research compound in this draft [3]